Display options
Cite
Aaby P, Benn C, Nielsen J, et al. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open. 2012;2(3)doi: 10.1136/bmjopen-2011-000707.
Aaby, P., Benn, C., Nielsen, J., Lisse, I. M., Rodrigues, A., & Ravn, H. (2012). Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ open, 2(3), . https://doi.org/10.1136/bmjopen-2011-000707
Aaby, Peter, et al. "Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries." BMJ open vol. 2,3 (2012). doi: https://doi.org/10.1136/bmjopen-2011-000707
Aaby P, Benn C, Nielsen J, Lisse IM, Rodrigues A, Ravn H. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open. 2012 May 22;2(3). doi: 10.1136/bmjopen-2011-000707. Print 2012. PMID: 22619263; PMCID: PMC3364456.
Copy Download .nbib Format: NLM
Share it on

BMJ Open. 2012 May 22;2(3). doi: 10.1136/bmjopen-2011-000707. Print 2012.

Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries.

BMJ open

Peter Aaby, Christine Benn, Jens Nielsen, Ida Maria Lisse, Amabelia Rodrigues, Henrik Ravn

Affiliations

  1. Bandim Health Project, INDEPTH Network, Statens Serum Institut, Bissau, Guinea-Bissau.

PMID: 22619263 PMCID: PMC3364456 DOI: 10.1136/bmjopen-2011-000707

Abstract

BACKGROUND: Measles vaccines (MV) have sex-differential effects on mortality not explained by protection against measles infection.

OBJECTIVE: The authors examined whether whole-cell diphtheria-tetanus-pertussis (DTP) vaccine has sex-differential and non-specific effects.

DATA SOURCES AND ELIGIBILITY: Following previous reviews and a new search, the effect of DTP on mortality up to the next vaccination was assessed in all studies where DTP was given after BCG or DTP was given after MV and there was prospective follow-up after ascertainment of vaccination status.

SETTING: High-mortality countries in Africa and Asia.

METHODS: The initial observation of negative effect of DTP generated six hypotheses, which were examined in all available studies and two randomised trials reducing the time of exposure to DTP.

MAIN OUTCOME: Consistency between studies.

RESULTS: In the first study, DTP had negative effects on survival in contrast to the beneficial effects of BCG and MV. This pattern was repeated in the six other studies available. Second, the two 'natural experiments' found significantly higher mortality for DTP-vaccinated compared with DTP-unvaccinated children. Third, the female-male mortality ratio was increased after DTP in all nine studies; in contrast, the ratio was decreased after BCG and MV in all studies. Fourth, the increased female mortality associated with high-titre measles vaccine was found only among children who had received DTP after high-titre measles vaccine. Fifth, in six randomised trials of early MV, female but not male mortality was increased if DTP was likely to be given after MV. Sixth, the mortality rate declined markedly for girls but not for boys when DTP-vaccinated children received MV. The authors reduced exposure to DTP as most recent vaccination by administering a live vaccine (MV and BCG) shortly after DTP. Both trials reduced child mortality.

CONCLUSIONS: These observations are incompatible with DTP merely protecting against the targeted diseases. With herd immunity to whooping cough, DTP is associated with higher mortality for girls. Randomised studies of DTP are warranted to measure the true impact on survival.

References

  1. Epidemiology. 2006 Sep;17(5):562-8 - PubMed
  2. Vaccine. 2007 Mar 30;25(14):2733-41 - PubMed
  3. PLoS Pathog. 2006 Jul;2(7):e65 - PubMed
  4. Vaccine. 2005 Jun 10;23(30):3991-8 - PubMed
  5. Vaccine. 2005 Jan 19;23(9):1197-204 - PubMed
  6. Arch Dis Child. 2002 Nov;87(5):386-7 - PubMed
  7. Lancet. 2003 Jun 28;361(9376):2183-8 - PubMed
  8. Lancet. 2003 Jun 28;361(9376):2169-70 - PubMed
  9. Bull World Health Organ. 1990;68(4):441-7 - PubMed
  10. Int J Epidemiol. 2005 Feb;34(1):138-48 - PubMed
  11. BMJ. 2001 Feb 10;322(7282):360 - PubMed
  12. Wkly Epidemiol Rec. 2008 Aug 8;83(32):287-92 - PubMed
  13. BMJ. 2005 Apr 9;330(7495):845-6 - PubMed
  14. Arch Dis Child. 2010 Sep;95(9):662-7 - PubMed
  15. Vaccine. 2009 May 11;27(21):2891-8 - PubMed
  16. Infect Immun. 1997 Feb;65(2):623-9 - PubMed
  17. Wkly Epidemiol Rec. 2010 May 28;85(22):197-212 - PubMed
  18. Pediatr Infect Dis J. 2004 Dec;23(12):1086-92 - PubMed
  19. Vaccine. 2001 Nov 12;20(3-4):468-74 - PubMed
  20. Vaccine. 2005 Jan 26;23(10):1251-7 - PubMed
  21. Vaccine. 2003 Jun 20;21(21-22):2782-90 - PubMed
  22. Int J Epidemiol. 2004 Apr;33(2):374-80 - PubMed
  23. BMJ. 1995 Aug 19;311(7003):481-5 - PubMed
  24. Int J Epidemiol. 2003 Oct;32(5):822-8 - PubMed
  25. Trop Med Int Health. 2007 Jan;12(1):15-24 - PubMed
  26. BMJ. 2010 Mar 15;340:c671 - PubMed
  27. Pediatr Infect Dis J. 2004 Jun;23(6):555-8 - PubMed
  28. J Virol. 1994 Aug;68(8):5126-32 - PubMed
  29. Pediatr Infect Dis J. 2010 Apr;29(4):324-8 - PubMed
  30. Lancet. 2004 Dec 18-31;364(9452):2204-11 - PubMed
  31. Int J Epidemiol. 2009 Feb;38(1):320-3; author reply 323-4 - PubMed
  32. Bull World Health Organ. 1994;72(5):761-70 - PubMed
  33. Proc R Soc Med. 1965 May;58:295-300 - PubMed
  34. BMJ. 2004 Dec 4;329(7478):1297-8 - PubMed
  35. Int J Epidemiol. 2003 Feb;32(1):106-16 - PubMed
  36. Scand J Public Health. 2010 Feb;38(1):95-103 - PubMed
  37. Epidemiol Infect. 1994 Apr;112(2):413-20 - PubMed
  38. Vaccine. 1994 Nov;12(14):1311-6 - PubMed
  39. Lancet. 1997 Jul 12;350(9071):101-5 - PubMed
  40. Trop Med Int Health. 2007 Jan;12(1):1-4 - PubMed
  41. J Pediatr. 1993 Jun;122(6):904-8 - PubMed
  42. Pediatr Infect Dis J. 2006 Aug;25(8):721-7 - PubMed
  43. Am J Epidemiol. 1996 May 15;143(10):1035-41 - PubMed
  44. Lancet. 1981 Apr 4;1(8223):764-7 - PubMed
  45. BMJ. 2010 Nov 30;341:c6495 - PubMed
  46. Trop Med Int Health. 2005 Oct;10(10):947-55 - PubMed
  47. Nature. 1976 Jan 29;259(5541):309-11 - PubMed
  48. Trop Med Int Health. 2005 Oct;10(10):956-60 - PubMed
  49. Vaccine. 2002 May 31;20 Suppl 3:S48-50 - PubMed
  50. J Infect. 1984 Jan;8(1):13-21 - PubMed
  51. Vaccine. 2006 May 29;24(22):4701-8 - PubMed
  52. Vaccine. 2007 Jan 15;25(5):777-9 - PubMed
  53. Wkly Epidemiol Rec. 2004 Jul 16;79(29):269-72 - PubMed
  54. Bull World Health Organ. 1978;56(5):773-80 - PubMed
  55. J Infect Dis. 1999 Sep;180(3):579-85 - PubMed
  56. N Engl J Med. 2000 Jun 22;342(25):1878-86 - PubMed
  57. Pediatr Infect Dis J. 2007 Mar;26(3):247-52 - PubMed
  58. Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):326-30 - PubMed
  59. BMJ. 2010 Mar 09;340:c1101 - PubMed
  60. Pediatr Infect Dis J. 2012 Mar;31(3):306-8 - PubMed
  61. Int J Epidemiol. 2005 Jun;34(3):540-7 - PubMed
  62. J Infect Dis. 2000 Oct;182(4):1029-38 - PubMed
  63. Vaccine. 2005 Feb 25;23(14):1637-8 - PubMed
  64. Int J Epidemiol. 2007 Oct;36(5):1022-9 - PubMed
  65. Am J Epidemiol. 1995 Sep 15;142(6):643-52 - PubMed
  66. Int J Epidemiol. 1991 Jun;20(2):474-9 - PubMed
  67. Pediatr Infect Dis J. 1989 Apr;8(4):197-200 - PubMed
  68. N Engl J Med. 2000 Jun 22;342(25):1887-92 - PubMed
  69. J Nutr. 2009 Nov;139(11):2154S-218S - PubMed
  70. Int J Epidemiol. 2009 Apr;38(2):586-90 - PubMed
  71. Cell Host Microbe. 2011 May 19;9(5):355-61 - PubMed
  72. Vaccine. 2006 Apr 5;24(15):2764-71 - PubMed
  73. Pediatr Infect Dis J. 2010 May;29(5):457-61 - PubMed
  74. Vaccine. 2002 Nov 22;21(1-2):120-6 - PubMed
  75. J Infect Dis. 2011 Jul 15;204(2):245-52 - PubMed
  76. Vaccine. 2007 Jan 26;25(7):1265-9 - PubMed
  77. Pediatr Infect Dis J. 2003 Sep;22(9):798-805 - PubMed
  78. BMJ. 2008 Jul 24;337:a661 - PubMed
  79. BMJ. 2004 Dec 4;329(7478):1309 - PubMed
  80. Int J Epidemiol. 2004 Apr;33(2):367-73 - PubMed
  81. Popul Stud (Camb). 1971 Nov;25(3):505-33 - PubMed
  82. J Immunol. 2002 Jan 15;168(2):919-25 - PubMed
  83. Pediatr Infect Dis J. 1996 Jan;15(1):39-44 - PubMed
  84. J Infect Dis. 1993 Nov;168(5):1087-96 - PubMed
  85. Lancet. 2008 Dec 13;372(9655):2031-46 - PubMed
  86. Vaccine. 2002 Nov 22;21(1-2):15-20 - PubMed
  87. Pediatr Infect Dis J. 2012 Oct;31(10):1095-7 - PubMed
  88. Bull World Health Organ. 2003;81(11):821-6 - PubMed
  89. Vaccine. 2005 Feb 25;23(14):1746-51 - PubMed
  90. Am J Clin Nutr. 2009 Sep;90(3):629-39 - PubMed
  91. Int J Epidemiol. 2005 Feb;34(1):149-51 - PubMed
  92. J Hyg (Lond). 1963 Mar;61:143-7 - PubMed
  93. Am J Epidemiol. 1993 Nov 1;138(9):746-55 - PubMed
  94. Trop Med Int Health. 2007 Jan;12(1):5-14 - PubMed
  95. Vaccine. 2005 Mar 31;23(19):2407-8 - PubMed
  96. Vaccine. 2011 Jan 10;29(3):487-500 - PubMed
  97. Lancet. 2009 Apr 25;373(9673):1428 - PubMed
  98. Immunol Today. 1998 Mar;19(3):113-6 - PubMed
  99. Int J Epidemiol. 2009 Feb;38(1):304-11 - PubMed
  100. Arch Dis Child. 2012 Aug;97(8):685-91 - PubMed
  101. Int J Epidemiol. 1996 Jun;25(3):665-73 - PubMed
  102. BMJ. 2008 Jun 21;336(7658):1416-20 - PubMed
  103. Bull World Health Organ. 1989;67(4):443-8 - PubMed
  104. Pediatr Infect Dis J. 2004 Jun;23(6):544-50 - PubMed
  105. BMJ. 2000 Dec 9;321(7274):1435-8 - PubMed
  106. Vaccine. 2006 May 29;24(22):4737-46 - PubMed
  107. Vaccine. 2004 Aug 13;22(23-24):3014-7 - PubMed
  108. Nat Rev Immunol. 2002 Jun;2(6):417-26 - PubMed
  109. J Immunol. 1993 Aug 15;151(4):2032-40 - PubMed

Publication Types

Grant support